Theravance Biopharma
TBPH
#6974
Rank
$0.55 B
Marketcap
Country
$11.06
Share price
0.27%
Change (1 day)
9.40%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Total assets
Total assets on the balance sheet as of March 2025 : $0.34 Billion USD
According to Theravance Biopharma 's latest financial reports the company's total assets are $0.34 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Theravance Biopharma - Total assets on balance sheet (from 2013 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $0.35 B | -7.29% |
| 2023-12-31 | $0.38 B | -37.11% |
| 2022-12-31 | $0.60 B | 62.05% |
| 2021-12-31 | $0.37 B | -20.09% |
| 2020-12-31 | $0.46 B | 14.73% |
| 2019-12-31 | $0.40 B | -27.03% |
| 2018-12-31 | $0.56 B | 26.92% |
| 2017-12-31 | $0.44 B | -30.95% |
| 2016-12-31 | $0.63 B | 113% |
| 2015-12-31 | $0.30 B | -11.15% |
| 2014-12-31 | $0.33 B | 1241.59% |
| 2013-12-31 | $25.17 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Collegium Pharmaceutical
COLL | $1.63 B | 374.82% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.84 B | 146.36% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.90 B | 164.53% | 🇺🇸 USA |
 Catalent CTLT | $9.70 B | 2,725.53% | 🇺🇸 USA |